Dr Paul Langely – Page 10 – Maimon Research LLC

After the QALY? Failing to recognize Rasch Measurement in proposing the EQ-Health and Wellbeing (EQ-HWB) instrument as an interval scale to support therapy response claims and QALYS

December 24, 2022 Dr Paul Langely 684 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Latest Working Papers

Evaluating Disease Specific Patient Reported Outcomes Measures for Rasch Interval Score Application

November 13, 2022 Dr Paul Langely 725 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Latest Working Papers

Post-Menopausal Quality of Life Claims: Overlooking the requirements of fundamental measurement in ICER’s cost-effectiveness assessment of fezolinetant for moderate to severe vasomotor symptoms

October 17, 2022 Dr Paul Langely 741 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Latest Working Papers

RASCH MEASUREMENT AND PATIENT REPORTED VALUE CLAIMS: A PRIMER FOR HEMOPHILIA

October 14, 2022 Dr Paul Langely 1034 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Latest Working Papers

Formulary Submissions: Value Claims, Protocols, and Outcomes Based Contracting in Rare Disease

August 17, 2022 Dr Paul Langely 771 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Latest Working Papers

Evidentiary standards for patient-centric core impact (PC-CIS) value claims

August 1, 2022 Dr Paul Langely 1096 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Latest Working Papers

Another Own Goal: ICER’s imaginary claims for the cost-effectiveness and pricing of weight management therapies

July 27, 2022 Dr Paul Langely 911 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Latest Working Papers

Facilitating Bias in Cost-Effectiveness Analysis: Assumption Driven Imaginary Value Claims in Health Technology Assessment

June 24, 2022 Dr Paul Langely 876 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Latest Working Papers

Rejecting Pseudoscience: Ten Commandments for Rare Disease Pricing and Reimbursement

May 22, 2022 Dr Paul Langely 1198 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Latest Working Papers

Concerns with Patient Reported Outcome Measurement and Value Claims: The Case of Mavacamten and Symptomatic Hypertrophic Cardiomyopathy (SHCM):

May 13, 2022 Dr Paul Langely 934 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.